Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Shares Repurchased (2016 - 2025)

Pediatrix Medical (MD) has disclosed Shares Repurchased for 12 consecutive years, with $64.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Shares Repurchased rose 9859.25% to $64.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $86.7 million, a 4990.02% increase, with the full-year FY2025 number at $86.7 million, up 4990.02% from a year prior.
  • Shares Repurchased was $64.0 million for Q4 2025 at Pediatrix Medical, up from $20.9 million in the prior quarter.
  • In the past five years, Shares Repurchased ranged from a high of $64.4 million in Q2 2022 to a low of $11000.0 in Q2 2023.
  • A 5-year average of $10.1 million and a median of $1.0 million in 2022 define the central range for Shares Repurchased.
  • Peak YoY movement for Shares Repurchased: soared 25556.57% in 2022, then plummeted 99.98% in 2023.
  • Pediatrix Medical's Shares Repurchased stood at $2.5 million in 2021, then plummeted by 40.58% to $1.5 million in 2022, then plummeted by 90.95% to $133000.0 in 2023, then skyrocketed by 383.46% to $643000.0 in 2024, then skyrocketed by 9859.25% to $64.0 million in 2025.
  • Per Business Quant, the three most recent readings for MD's Shares Repurchased are $64.0 million (Q4 2025), $20.9 million (Q3 2025), and $209000.0 (Q2 2025).